Introduction {#Sec1}
============

Podocarpane diterpenoids usually possessed a backbone of seventeen carbons arranged in a tricyclohexane system close to abietane and pimarane \[[@CR1]--[@CR8]\]. They do not occur extensively in nature but are present in several genera, such as *Azadirachta* \[[@CR1]--[@CR5]\], *Humirianthera* \[[@CR6]\], *Micrandropsis* \[[@CR7]\], and *Podocarpus* \[[@CR8]\]. Previous studies have disclosed a few biologically active podocarpane molecules, such as 13-hydroxy-8,11,13-podocarpatriene-19-oic acid, a highly fungistatic agent \[[@CR9], [@CR10]\], and 7-oxo-13-hydroxy-14-amino-8,11,13-podocarpatriene, a potent 5-lipoxygenase inhibitor \[[@CR11]\].

*Anemone hupehensis* is a flowering herbaceous perennial in the Ranunculaceae family. It is about one meter high and native in central China. In previous chemical studies on this plant, a few triterpenoids and their saponins were reported \[[@CR12]--[@CR15]\]. In our continuous searching for new and bioactive natural products, we investigated the chemical constituents in aerial parts of *A. hupehensis*, which resulted in the isolation of three new podocarpane diterpenoids, anemhupehins A--C (**1**--**3**), as well as four known ones **4**--**7** (Fig. [1](#Fig1){ref-type="fig"}). Compound **4** was isolated as a new natural product for the first time. Their structures were established by extensive spectroscopic methods. Compounds **1** and **4**--**7** were evaluated for their cytotoxicities against five human cancer cell lines. We report here the isolation, structure elucidation, and cytotoxicities of these isolates.Fig. 1Structures of compounds **1**--**7**

Results and Discussion {#Sec2}
======================

Compound **1** was isolated as a colorless oil. The HRESIMS data at *m/z* 283.1668 \[M + Na\]^+^ (calcd for C~17~H~24~O~2~Na: 283.1669) indicated a molecular formula C~17~H~24~O~2~, requiring six degrees of unsaturation. The IR absorption bands at 3438, 1608, and 1480 cm^−1^ were attributable to hydroxy and phenyl groups. In the ^1^H NMR spectrum (Table [1](#Tab1){ref-type="table"}), three singlets from at *δ* ~H~ 1.04 (3H), 1.27 (3H), and 1.54 (3H) were readily identified signals for three methyls, while three signals at *δ* ~H~ 6.49 (1H, d, *J* = 2.8 Hz, H-14), 6.67 (1H, dd, *J* = 8.6, 2.8 Hz, H-12), and 7.17 (1H, d, *J* = 8.6 Hz, H-11) displayed a 1,3,4-trisubstituted aromatic ring. The ^13^C NMR data, with the aid of DEPT and HSQC spectra, revealed 17 carbon resonances ascribable for three methyl, four methylene, five methine, and five quaternary carbons (Table [1](#Tab1){ref-type="table"}). Analyses of ^1^H--^1^H COSY data disclosed three spin-coupling systems shown in Fig. [2](#Fig2){ref-type="fig"}. These data, together with preliminary analyses of HMBC correlations, suggested that **1** possessed a podocarpane skeleton. A phenolic hydroxy group at *δ* ~H~ 5.22 (1H, s) was deduced to be placed at C-13 by analyses of HMBC correlations and NMR data. In addition, another hydroxy group was suggested to be at C-6, as revealed by HMBC correlations from *δ* ~H~ 4.67 (1H, br d, *J* = 5.0 Hz, H-6) to *δ* ~C~ 53.4 (d, C-5), 41.3 (t, C-7), 34.3 (s, C-4), and 37.2 (s, C-10), as well as ^1^H--^1^H COSY cross peaks of H-6/*δ* ~H~ 1.40 (1H, br s, H-5) and H-6/*δ* ~H~ 3.10 and 2.85 (2H, H~2~-7). These data elucidated the structure of **1** to be 6,13-dihydroxy-8,11,13-podocarpatriene. An ROESY experiment revealed the relative configuration of **1** (Fig. [2](#Fig2){ref-type="fig"}), in which the cross peak of H-19/H-20 indicated that CH~3~-19 and CH~3~-20 were in the same side (*β* orientation), while the cross peaks of H-18/H-5, H-5/H-6, and H-6/H-18 indicated that H-6 should be *α* oriented. As established by the ROESY data, the energy minimized 3D structure of **1** revealed stereoconfiguration of **1**. A Newman projection of C-5 and C-6 indicated the dihedral angle between H-5 and H-6 to be close to *θ* = 90° (Fig. [2](#Fig2){ref-type="fig"}), which resulted in the coupling constants of *J* ~5,6~ = 0 Hz, that is why H-5 presented as a singlet in the ^1^H NMR spectrum. All these data elucidated the structure of **1** to be 6*β*,13-dihydroxy-8,11,13-podocarpatriene, named anemhupehin A.Table 1^1^H and ^13^C NMR data for compounds **1**--**3** (*δ* in ppm, *J* in Hz)^a^No.**123***δ* ~H~*δ* ~C~*δ* ~H~*δ* ~C~*δ* ~H~*δ* ~C~12.15 (1H, br d, 12.6)\
1.36 (1H, m)42.4 (t)2.21 (1H, br d, 12.7)\
1.31 (1H, m)39.1 (t)2.21 (1H, br d, 12.6)\
1.31 (1H, m)38.7 (t)21.83 (1H, m)\
1.60 (1H, m)19.7 (t)1.72 (1H, m)\
1.58 (1H, m)19.3 (t)1.72 (1H, m)\
1.58 (1H, m)19.4 (t)31.46 (1H, m)\
1.24 (1H, m)43.2 (t)1.48 (1H, m)\
1.21 (1H, m)41.4 (t)1.48 (1H, m)\
1.21 (1H, m)41.6 (t)434.3 (s)33.3 (s)33.1 (s)51.40 (1H, br s)53.4 (d)1.35 (1H, dd, 13.1, 3.8)49.4 (d)1.60 (1H, m)44.9 (d)64.67 (1H, br d, 5.0)66.2 (d)2.24 (1H, m)\
1.64 (1H, m)30.3 (t)1.98 (2H, m)28.7 (t)73.10 (1H, dd, 17.4, 5.0)\
2.85 (1H, d, 17.4)41.3 (t)4.75 (1H, m)71.4 (d)4.76 (1H, m)68.4 (d)8133.1 (s)139.5 (s)137.6 (s)9141.3 (s)142.5 (s)142.6 (s)1037.2 (s)38.1 (s)37.7 (s)117.17 (1H, d, 8.6)126.7 (d)7.10 (1H, d, 8.7)126.1 (d)7.14 (1H, d, 8.4)126.1 (d)126.67 (1H, dd, 8.6, 2.8)113.9 (d)6.72 (1H, dd, 8.7, 2.7)115.1 (d)6.74 (1H, dd, 8.4, 2.6)116.0 (d)13153.3 (s)153.7 (s)153.7 (s)146.49 (1H, d, 2.8)115.5 (d)6.99 (1H, d, 2.7)113.3 (d)6.82 (1H, d, 2.6)116.0 (d)181.04 (3H, s)33.9 (q)0.95 (3H, s)33.2 (q)0.97 (3H, s)33.3 (q)191.27 (3H, s)23.9 (q)0.92 (3H, s)21.7 (q)0.92 (3H, s)21.7 (q)201.54 (3H, s)27.3 (q)1.22 (3H, s)25.6 (q)1.10 (3H, s)24.2 (q)OH5.22 (1H, br s)4.96 (1H, br s)5.37 (1H, br s)The assignments were based on DEPT, ^1^H-^1^H COSY, HSQC, and HMBC experiments^a^Data (*δ*) were measured in CDCl~3~ Fig. 2Key 2D NMR correlations of **1** and stereoconfiguration analyses

Compound **2** was isolated as a colorless oil. The HRESIMS established the molecular formula to be C~17~H~24~O~2~ on the basis of a molecular ion peak at *m/z* 259.1704 (calcd for C~17~H~23~O~2~: 259.1704 \[M − H\]^−^). IR absorption bands (3432, 1612, 1481 cm^−1^) also indicated the presence of hydroxy and phenyl functions. The ^13^C NMR and DEPT disclosed 17 carbon resonances including three methyl, four methylene, five methine, and five quaternary carbons (Table [1](#Tab1){ref-type="table"}). These data showed similar patterns to those of **1**. The ^1^H--^1^H COSY cross peak between *δ* ~H~ 4.75 (1H, m, H-7) and 2.24/1.64 (each 1H, m, H-6), as well as HMBC correlations from H-7 to *δ* ~C~ 139.5 (s, C-8) and 30.3 (t, C-6) suggested that a hydroxy should be placed at C-7 in **2**, rather than at C-6 in **1**. Detailed analyses of 2D NMR data indicated that the other parts of **2** were the same to those of **1**. In the ROESY spectrum, cross peaks of H-5/H-7 suggested that OH-7 should be *β* oriented. Therefore, compound **2** was elucidated as 7*β*,13-dihydroxy-8,11,13-podocarpatriene, named anemhupehin B.

Compound **3** was initially isolated as a mixture with **2**. A further isolation of this mixture only obtained pure compound **2**, while the amount of compound **3** is too less to obtain the clear NMR spectra. However, careful analyses of MS data of **3** and NMR spectra of the mixture (see Supporting Information), with the aid of NMR spectrum of **2**, can unambiguously elucidate the structure of **3**. The HRESIMS of **3** displayed a molecular ion peak at *m/z* 259.1704 (calcd for C~17~H~23~O~2~: 259.1704 \[M − H\]^−^), revealed the molecular formula C~17~H~24~O~2~, the same to that of **2**. The ^13^C NMR data also showed good agreements with those of **2**. Analyses of 1D and 2D NMR data suggested that compound **3** should have the same planar structure to that of **1**. However, the ^13^C NMR shift of C-7 at *δ* ~C~ 68.4 in **3** was significantly different from that in **2**, indicating that compound **3** might be an epimer of **2**. In the ROESY spectrum of the mixture, the cross peaks of 19/H-20 and H-18/H-5 suggested that C-5 and C-10 possessed the same configurations to those in compounds **2**. Therefore, compound **3** was determined to be 7-epimer of **2**. The 3D structure analyses of **3** and **2** also supported that OH-7 in **3** should be *α* oriented. Therefore, compound **3** was elucidated as 7*α*,13-dihydroxy-8,11,13-podocarpatriene, named anemhupehin C.

Four known analogues were identified as 13,14-dihydroxy-8,11,13-podocarpatriene (**4**) \[[@CR16]\], 13-hydroxy-8,11,13-podocarpatriene (**5**) \[[@CR17]\], 13,14-dihydroxy-7-oxo-8,11,13-podocarpatriene (**6**) \[[@CR17]\], and 13-hydroxy-7-oxo-8,11,13-podocarpatriene (**7**) \[[@CR18]\]. Compound **4** was isolated as a natural product for the first time.

Compounds **1** and **4--7** were evaluated for their cytotoxicities to five human cancer cell lines. As a result, compounds **1** and **4** showed moderate activities as shown in Table [2](#Tab2){ref-type="table"}. The other compounds were inactive to cancer cell lines (IC~50~ \> 40 *μ*M).Table 2Cytotoxicities of compounds **1** and **4** (IC~50~, *μ*M)EntryHL-60SMMC-7721A-549MCF-7SW480**1**\> 4033.8\> 4028.813.2**4**16.822.7\> 4012.214.1Cisplatin4.412.416.417.112.8

Experimental {#Sec3}
============

General Experimental Procedures {#Sec4}
-------------------------------

Optical rotations were measured on a Jasco-P-1020 polarimeter. IR spectra were obtained using a Bruker Tensor 27 FT-IR spectrometer with KBr pellets. NMR spectra were acquired with a Bruker DRX-600 with tetramethylsilane (TMS) used as an internal standard. HRESIMS were recorded on an API QSTAR Pulsar spectrometer. Silica gel (200--300 mesh), Sephadex LH-20 and RP-18 gel (20--45 *µ*m) were used for column chromatography (CC). Medium pressure liquid chromatography (MPLC) was performed on a Biotage system. Preparative high performance liquid chromatography (prep-HPLC) was performed on an Agilent 1260 liquid chromatography system equipped with Zorbax SB-C18 columns (5 μm, 9.4 mm × 150 mm or 21.2 mm × 150 mm) and a DAD detector. Fractions were monitored by TLC and spots were visualized by heating silica gel plates immersed in H~2~SO~4~ in EtOH, in combination with the Agilent 1200 series HPLC system (Eclipse XDB-C18 column, 5 μm, 4.6 × 150 mm).

Plant Material {#Sec5}
--------------

Aerial parts of *A. hupehensis* were collected from ShenLongJia of Hubei province, central China in September 2016 and identified by Prof. Ming-Qing Pan of Wuhan University. A specimen (No. COP-HF20160912.4) was deposited at South-Central University for Nationalities.

Extraction and Isolation {#Sec6}
------------------------

The air dried sample of *A. hupehensis* (8 kg) were extracted with methanol (24 h × 3) to afford an extract. The extract was partitioned with water and EtOAc (1:1). The extract of EtOAc lay (202 g) was subjected to silica gel CC using CHCl~3~-MeOH (from 1:0 to 0:1) to give eight fractions (A--H). Fraction C (23.8 g) was separated by MPLC with gradient mixture of MeOH and H~2~O (20:80--100:0, v/v) to afford ten sub-fractions (C1--C10). Fraction C2 (500 mg) was isolated by silica gel CC using petroleum ether/Me~2~CO (6:1) to afford several subfractions, and compound **6** (13 mg) crystallized from one subfraction. Fraction C4 (280 mg) was purified by Sephadex LH-20 (MeOH) to give compounds **1** (7.2 mg) and **4** (8.6 mg). Compounds **2** and **3** was initially isolated as a mixture (2.8 mg) as obtained from fraction C5 (120 mg) by silica gel CC, and was re-purified by HPLC (MeCN:H~2~O (v/v) from 2:8 to 4:6 in 25 min) to afford pure compounds **2** (1.1 mg) and **3** (less than 0.5 mg). Fraction C6 (300 mg) was isolated by Sephadex LH-20 (MeOH) and then purified by HPLC (MeCN:H~2~O (v/v) from 3:7 to 4:6 in 25 min) to afford **5** (6.8 mg) and **7** (3.4 mg).

### Anemhupehin A (**1**) {#Sec7}

Colorless oil, $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \left[ \alpha \right]_{\text{D}}^{ 2 2} + 1 7. 6 $$\end{document}$ (*c* 0.18 MeOH); IR (KBr) ν~max~ 3443, 3438, 2928, 1624, 1608, 1480, 1367, 1201, 862 cm^−1^; for ^1^H (600 MHz) and ^13^C NMR (150 MHz) data (CDCl~3~), see Table [1](#Tab1){ref-type="table"}; HRESIMS: *m/z* 283.1668 (calcd for C~17~H~24~O~2~Na, \[M + Na\]^+^, 283.1669).

### Anemhupehin B (**2**) {#Sec8}

Colorless oil, $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \left[ \alpha \right]_{\text{D}}^{ 2 2} + 1 2. 7 $$\end{document}$ (*c* 0.08 MeOH); IR (KBr) ν~max~ 3441, 3432, 2926, 1612, 1481, 1381, 1211, 882 cm^−1^; for ^1^H (600 MHz) and ^13^C NMR (150 MHz) data (CDCl~3~), see Table [1](#Tab1){ref-type="table"}; HRESIMS: *m/z* 259.1704 (calcd for C~17~H~23~O~2~, \[M − H\]^−^, 259.1704).

### Anemhupehin C (**3**) {#Sec9}

Colorless oil, $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \left[ \alpha \right]_{\text{D}}^{ 2 2} + 8. 7 $$\end{document}$ (*c* 0.02 MeOH); for ^1^H (600 MHz) and ^13^C NMR (150 MHz) data (CDCl~3~), see Table [1](#Tab1){ref-type="table"}; HRESIMS: *m/z* 259.1704 (calcd for C~17~H~23~O~2~, \[M − H\]^−^, 259.1704).

Cytotoxicity Assay {#Sec10}
------------------

Human myeloid leukemia HL-60, hepatocellular carcinoma SMMC-7721, lung cancer A-549 cells, breast cancer MCF-7 and colon cancer SW480 cell lines were used in the cytoxic assay. All cell lines were cultured in RPMI-1640 or DMEM medium (Hyclone, USA), supplemented with 10% fetal bovine serum (Hyclone, USA) in 5% CO~2~ at 37 °C. The cytotoxicity assay was performed according to the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) method in 96-well microplates \[[@CR19]\]. Cisplatin was used as a positive control.
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